To facilitate timely access to social services in hospitals, high social risk (HSR) screening mechanisms have been implemented throughout the country. The purpose of these mechanisms is to identify patients upon admission who are most likely to need service. Because these screening mechanisms often identify patients who do not need service, this study determined how well the patient characteristics used as screening factors actually predicted service utilization. A multivariate logistic regression model was developed using 1,659 discharges from two midwestern hospitals. The most powerful predictors of social service use were age, multi-system illness, not having a spouse, and psychiatric co-morbidity. Despite the significant contribution of each predictor, their combined ability to predict who receives service was modest.

Download full-text PDF

Source
http://dx.doi.org/10.1300/J010v16n04_07DOI Listing

Publication Analysis

Top Keywords

screening mechanisms
12
high social
8
social risk
8
patient characteristics
8
predictors social
8
mechanisms identify
8
identify patients
8
service
5
screening
4
risk screening
4

Similar Publications

Objective: To determine the structure of abnormalities of bone tissue and substantiate the management tactics inacute lymphoblastic leukemia (ALL) pediatric patients and in children with no oncohematological disorders, livingin radiologically contaminated territories (RCT).

Materials And Methods: Children (n = 220) living in RCT were the study participants i.e.

View Article and Find Full Text PDF

Study Question: Does the risk of childhood cancer following ARTs vary by sex?

Summary Answer: In this registry-based study, some childhood cancers showed positive sex- and age-specific associations in children conceived using certain ART modalities, which were not evident in overall combined analyses.

What Is Known Already: The relationship between ART and risk of childhood cancer has shown diverse outcomes in prior research. Studies examining whether there are sex differences in childhood cancer risk after ART conception are lacking.

View Article and Find Full Text PDF

A bibliometric analysis of research trends and hotspots of pilocytic astrocytoma from 2004 to 2023.

Neurosurg Rev

December 2024

Department of Neurosurgery and Neuro-Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.

Pilocytic astrocytoma (PA) is a WHO grade I neoplasm with a favorable prognosis. It is the most common pediatric benign tumor. Recently, PA has attracted more and more attention and discussion from scholars.

View Article and Find Full Text PDF

Homologous recombination deficiency (HRD) is considered a universal and effective sign of a tumor's sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors. HRD diagnostics have undergone several stages of transformations: from detection of point mutations in HR-related genes and large regions with loss of heterozygosity detected using single-nucleotide polymorphism arrays to whole-genome signatures of single-nucleotide variants, large genomic rearrangements (LGRs), and copy number alterations. All these methods have their own advantages and limitations.

View Article and Find Full Text PDF

Exosomes, their sources, and possible uses in cancer therapy in the era of personalized medicine.

J Cancer Res Clin Oncol

December 2024

Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovakia.

Despite significant advances in immunotherapy, its efficacy in solid tumors remains limited. Exosomes, a primary type of extracellular vesicles, can transport diverse intracellular molecules to nearby or distant cells and organs, facilitating numerous biological functions. Research has shown that exosomes have the dual ability to both activate and suppress the immune system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!